Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

Longer titles found: Individualized cancer immunotherapy (view)

searching for Cancer immunotherapy 196 found (302 total)

alternate case: cancer immunotherapy

Sean Parker (4,763 words) [view diff] case mismatch in snippet view article find links to article

Parker donated $250 million to create the Parker Institute for Cancer Immunotherapy, in April 2016. The funds initially went to over 300 scientists at
Resiquimod (562 words) [view diff] exact match in snippet view article find links to article
demonstrated through nanoparticle encapsulation, resulting in effective cancer immunotherapy through stimulation of tumor-associated macrophages. It has several
William B. Coley Award (713 words) [view diff] case mismatch in snippet view article find links to article
system. For this reason, Coley has become known as the "Father of Cancer Immunotherapy." Source: 1975: Garry Abelev 000 – Edward A. Boyse 000 – Edgar J
Juno Therapeutics (589 words) [view diff] exact match in snippet view article find links to article
investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and
Nicholas P. Restifo (669 words) [view diff] exact match in snippet view article find links to article
24, 1960) is an American immunologist, physician and educator in cancer immunotherapy. Until July 2019, he was a tenured senior investigator in the intramural
Cowpea mosaic virus (500 words) [view diff] exact match in snippet view article find links to article
CPMV particles have also shown potential for in-situ vaccination in cancer immunotherapy Q. Wang, T. Lin, L. Tang, J.E. Johnson, and M.G. Finn.Angew. Chem
Bugula neritina (433 words) [view diff] exact match in snippet view article find links to article
under investigation for their therapeutic potential directed at cancer immunotherapy, treatment of Alzheimer's disease, and HIV/AIDS eradication, due
NT5E (2,293 words) [view diff] exact match in snippet view article find links to article
adenosine for cancer immunotherapy 2018 Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities 2016 CD73 as a potential opportunity for cancer immunotherapy
Molecular oncology (1,076 words) [view diff] exact match in snippet view article find links to article
PMID 30721651 – via Web of Science. Helmy, KY; Patel, SA (October 2013). "Cancer immunotherapy: accomplishments to date and future promise". Therapeutic Delivery
Interleukin 21 (2,923 words) [view diff] no match in snippet view article find links to article
Interleukin 21 (IL-21) is a protein that in humans is encoded by the IL21 gene. Interleukin-21 is a cytokine that has potent regulatory effects on cells
Alex Marson (607 words) [view diff] case mismatch in snippet view article find links to article
also currently holds affiliations with the Parker Institute for Cancer Immunotherapy (PICI), the Chan Zuckerberg Biohub, and the Innovative Genomics Institute
Agenus (912 words) [view diff] exact match in snippet view article find links to article
patients. In light of the advances made, Science magazine hailed cancer immunotherapy as its 2013 Breakthrough of the Year. Agenus (formerly Antigenics
John H. Abeles (252 words) [view diff] exact match in snippet view article find links to article
synthetic form of brystatin-1 from Stanford University for the use in cancer immunotherapy and adjunctive therapy. Abeles received his medical degree as well
Susan Kaech (181 words) [view diff] exact match in snippet view article find links to article
focuses on the formation of memory T cells, T cell metabolism, and cancer immunotherapy. Kaech conducted her undergraduate studies at the University of Washington
Ruth S. Waterman (489 words) [view diff] exact match in snippet view article find links to article
company that specializes in next generation stem cell therapy and cancer immunotherapy. Waterman is known for developing stem cell-based therapies to help
The Immune Response Corporation (1,786 words) [view diff] exact match in snippet view article find links to article
available cancer immunotherapy, Novartis purchased the process and the FDA-approved facility and hired 100 people who were making the prostate cancer immunotherapy
Badri Roysam (634 words) [view diff] exact match in snippet view article find links to article
multidimensional images. Roysam's work as a researcher focuses on cancer immunotherapy and neuroscience. In addition to interdisciplinary collaborations
Akkermansia muciniphila (1,342 words) [view diff] no match in snippet view article find links to article
Akkermansia muciniphila is a species of human intestinal mucin-degrading bacterium, the type species for a new genus, Akkermansia, proposed in 2004 by
Faron Pharmaceuticals (203 words) [view diff] exact match in snippet view article find links to article
development of treatments for acute organ traumas, vascular damage and cancer immunotherapy. Its lead product Traumakine has been developed to treat Acute Respiratory
Jeffrey Bluestone (571 words) [view diff] case mismatch in snippet view article find links to article
also serves as the President and CEO of the Parker Institute for Cancer Immunotherapy He started his career as an investigator in the immunology branch
Fred Ramsdell (230 words) [view diff] case mismatch in snippet view article find links to article
2016, he has been Research Director at the Parker Institute for Cancer Immunotherapy in San Francisco. Ramsdell and team identified Forkhead Box Protein
Clevegen (187 words) [view diff] exact match in snippet view article find links to article
Clevegen is a new cancer immunotherapy drug under development in Finland by Faron Pharmaceuticals. The drug is an anti-Clever-1 antibody which can convert
Wolfram Samlowski (1,625 words) [view diff] exact match in snippet view article find links to article
interests include translational research and development of novel cancer immunotherapy agents, translational drug development as well as gene therapy. His
Dmitry Gabrilovich (438 words) [view diff] exact match in snippet view article find links to article
peroxynitrite, causing them to become resistant to certain types of cancer immunotherapy. His research has also focused on monocytic-myeloid derived suppressor
Philosophy of biology (2,410 words) [view diff] exact match in snippet view article find links to article
chose cancer immunotherapy as the breakthrough of 2013. According to their explanation a lesson to be learned from the successes of cancer immunotherapy is
Weiping Zou (847 words) [view diff] exact match in snippet view article find links to article
Choi JE, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 2019; 569:270-274 Zou W. Mechanistic insights into cancer
Paul Terasaki (1,320 words) [view diff] exact match in snippet view article find links to article
creation of the Terasaki Foundation, a research center dedicated to cancer immunotherapy and the study of humoral immunity and transplantation. On May 13
Nivolumab (2,556 words) [view diff] exact match in snippet view article find links to article
Draghi A, Borch TH, Nuti M, Cortesi E, Svane IM, Donia M (May 2018). "Cancer immunotherapy in patients with brain metastases". Cancer Immunology, Immunotherapy
Stanford Cancer Institute (237 words) [view diff] case mismatch in snippet view article find links to article
2016, a new center was created as part of the Parker Institute for Cancer Immunotherapy. Stanford received $10 million from the Parker Foundation. This is
Blocking antibody (692 words) [view diff] exact match in snippet view article find links to article
2013). "At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy". Journal of Leukocyte Biology. 94: 41–53. doi:10.1189/jlb.1212631
Tumor antigens recognized by T lymphocytes (2,553 words) [view diff] exact match in snippet view article find links to article
cancer progression and metastasis. The purpose of T cell-mediated cancer immunotherapy is to reactivate these responses to a degree that results in tumor
Electroporation (5,099 words) [view diff] exact match in snippet view article find links to article
produce cells with desired properties, such as in cell vaccines for cancer immunotherapy. However, the first and most known application of cell fusion is
Imugene (1,144 words) [view diff] exact match in snippet view article find links to article
Imugene Ltd is a biotechnology company working in cancer immunotherapy. The company's lead product is HER-Vaxx, a therapeutic cancer vaccine for the treatment
Artificial antigen presenting cells (836 words) [view diff] exact match in snippet view article find links to article
antigen presenting cells (aAPCs) are a new technology and approach to cancer immunotherapy. Immunotherapy aims to utilize the body’s own defense mechanism—the
Crystal Mackall (760 words) [view diff] case mismatch in snippet view article find links to article
for Cancer Immunotherapy. Retrieved 2019-06-17.[verification needed] "Crystal Mackall, MD". parkerici.org. Parker Institute for Cancer Immunotherapy. Retrieved
K. Christopher Garcia (2,304 words) [view diff] exact match in snippet view article find links to article
several studies targeting cellular receptors for applications in cancer immunotherapy. In 2013, Garcia's group developed high affinity antagonists of the
Ludwig Cancer Research (2,022 words) [view diff] exact match in snippet view article find links to article
contributed to the immunosurveillance hypothesis, from which modern cancer immunotherapy can be derived. Thierry Boon, former director of the organization’s
Antigen-presenting cell (2,150 words) [view diff] exact match in snippet view article find links to article
(2014-01-01). "Human cell-based artificial antigen-presenting cells for cancer immunotherapy". Immunological Reviews. 257 (1): 191–209. doi:10.1111/imr.12129
Mir-339 microRNA precursor family (626 words) [view diff] exact match in snippet view article find links to article
(August 2010). "MicroRNAs in immune regulation--opportunities for cancer immunotherapy". The International Journal of Biochemistry & Cell Biology. 42 (8):
Nancy Y. Lee (448 words) [view diff] case mismatch in snippet view article find links to article
RTOG's Head and Neck Cancer Working Group. Lee was a co-author on the Cancer Immunotherapy Guidelines for Head and Neck Cancer put forward by the Society for
Immutep (1,737 words) [view diff] exact match in snippet view article find links to article
Biomed) is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally
Tumor-associated macrophage (2,415 words) [view diff] exact match in snippet view article find links to article
expressed on TAMs, and could be a potential therapeutic target for cancer immunotherapy. TAMs have historically been described as falling into two categories:
Bavituximab (436 words) [view diff] exact match in snippet view article find links to article
2016 Mahoney KM, Rennert PD, Freeman GJ (August 2015). "Combination cancer immunotherapy and new immunomodulatory targets". Nature Reviews. Drug Discovery
MiR-146 (751 words) [view diff] exact match in snippet view article find links to article
MT (Aug 2010). "MicroRNAs in immune regulation--opportunities for cancer immunotherapy". The International Journal of Biochemistry & Cell Biology. 42 (8):
Elizabeth Jaffee (962 words) [view diff] case mismatch in snippet view article find links to article
Vaccines and Uses Thereof. In 2007, Dr. Elizabeth Jaffee co-authored “Cancer Immunotherapy: Immune Suppression and Tumor Growth”, a publication describing the
Polysaccharide-K (491 words) [view diff] exact match in snippet view article find links to article
effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy". Anticancer Research. 22 (3): 1737–54. PMID 12168863. American Cancer
Benaroya Research Institute (2,358 words) [view diff] case mismatch in snippet view article find links to article
Cancer Immunotherapy, JDRF and the Helmsley Charitable Trust Form Cancer and Diabetes Research Initiative". Parker Institute for Cancer Immunotherapy
CureVac (1,036 words) [view diff] exact match in snippet view article find links to article
Institute and Ludwig Cancer Research to enable clinical testing of novel cancer immunotherapy treatment options. On March 2014, CureVac won a €2 million prize
Survivin (8,349 words) [view diff] exact match in snippet view article find links to article
fragmented. Survivin has been a target of attention in recent years for cancer immunotherapy, as it is an antigen that is expressed mostly in cancer cells and
Dendritic cell-based cancer vaccine (1,511 words) [view diff] case mismatch in snippet view article find links to article
J. (2014-12-12). "Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy". The Yale Journal of Biology and Medicine. 87 (4): 491–518. ISSN 0044-0086
Ono Pharmaceutical (274 words) [view diff] case mismatch in snippet view article find links to article
Ltd". bloomberg.com. Retrieved October 4, 2018. "Spotlight on New Cancer Immunotherapy: Ono Pharmaceutical's Opdivo". Nippon.com. Retrieved October 4, 2018
SITC (104 words) [view diff] exact match in snippet view article find links to article
professional society for advancing the science and application of cancer immunotherapy Standard International Trade Classification, a classification of
Lucatumumab (427 words) [view diff] exact match in snippet view article find links to article
Sørensen JF, Olsen BN, Pedersen AE (April 2014). "Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials". Immunopharmacology
Urelumab (197 words) [view diff] case mismatch in snippet view article find links to article
S.; Chester, C.; Kim, J.; Kohrt, H. E. (2015-07-15). "Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy". Clinical Cancer Research. 21 (14):
Cardiff University School of Medicine (2,250 words) [view diff] case mismatch in snippet view article find links to article
CD59 Expression by Restrictive Silencer Factor–Derived Peptides in Cancer Immunotherapy for Neuroblastoma". Cancer Research. 73 (22): 6839. doi:10.1158/0008-5472
Polypurine reverse-Hoogsteen hairpin (1,328 words) [view diff] exact match in snippet view article find links to article
antiapoptotic survivin gene. PPRHs have also been applied as tools in cancer immunotherapy by silencing CD47 in MCF7 breast cancer cells and SIRPα in macrophages
GD2 (293 words) [view diff] exact match in snippet view article find links to article
PMID 24711551. 2. Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy. Ahmed M, Cheung NK. FEBS Lett. 2014 Jan 21;588(2):288-97 3. Neuroblastoma:
Merck & Co. (6,968 words) [view diff] exact match in snippet view article find links to article
Engineering & Biotechnology News. "Merck signs a $605M deal to bulk up in cancer immunotherapy". FierceBiotech. "Quartet, Merck Partner on Pain Treatments in Up-to-$595M
AbbVie Inc. (1,691 words) [view diff] case mismatch in snippet view article find links to article
Launch Cancer Research Alliance". GEN. "AbbVie to Co-Develop argenx's Cancer Immunotherapy ARGX-115 - GEN News Highlights - GEN". GEN. "AbbVie to Co-Commercialize
Spontaneous remission (982 words) [view diff] exact match in snippet view article find links to article
Grange, J. M. (2008). "Pathogen-associated molecular pattern in cancer immunotherapy". Critical Reviews in Immunology. 28 (2): 95–107. doi:10.1615/critrevimmunol
CD16 (1,482 words) [view diff] exact match in snippet view article find links to article
expression on neutrophils, CD16 represents a possible target in cancer immunotherapy. Margetuximab, an Fc-optimized monoclonal antibody that recognizes
CRM197 (1,388 words) [view diff] exact match in snippet view article find links to article
therapy. The cancer immunotherapy company Imugene reported dramatic improvements in antibody titers from its B cell peptide cancer immunotherapy targeting
Duane Mitchell (669 words) [view diff] exact match in snippet view article find links to article
early-phase clinical trials on RNA-transfected dendritic cells in cancer immunotherapy found that the use of Dendritic Cells transfected with RNA is an
List of immunologists (676 words) [view diff] exact match in snippet view article find links to article
immunology of reproduction William Coley (1862-1936), pioneer of cancer immunotherapy Albert Coons (1912-1978), developed immunofluorescent techniques
Ipilimumab (3,745 words) [view diff] case mismatch in snippet view article find links to article
Couzin-Frankel, Jennifer (20 December 2013). "Breakthrough of the Year: Cancer Immunotherapy". Science. 342 (6165): 1432–3. doi:10.1126/science.342.6165.1432
Sharon, Connecticut (1,346 words) [view diff] exact match in snippet view article find links to article
bone surgeon and inventor of "Coley's toxins", an early form of cancer immunotherapy Helen Coley Nauts (1907-2001), daughter of William Coley and co-founder
CD80 (1,532 words) [view diff] exact match in snippet view article find links to article
cell-mediated death via CD80 interactions has been explored as a possible cancer immunotherapy, through the induction of CD80 expression on tumor cells. Some therapies
Trifunctional antibody (1,379 words) [view diff] exact match in snippet view article find links to article
PMID 2859527. Mueller, D; Kontermann, RE (2010). "Bispecific antibodies for cancer immunotherapy". BioDrugs. 24 (2): 89–98. doi:10.2165/11530960-000000000-00000.
Sidney Kimmel Comprehensive Cancer Center (608 words) [view diff] case mismatch in snippet view article find links to article
Prostate Cancer, and SPORE programs. The Bloomberg–Kimmel Institute for Cancer Immunotherapy was founded with in 2016 two $50 million gifts from Michael R. Bloomberg
Mesothelin (2,591 words) [view diff] exact match in snippet view article find links to article
PMID 8552591. Hassan R, Ho M (January 2008). "Mesothelin targeted cancer immunotherapy". European Journal of Cancer. 44 (1): 46–53. doi:10.1016/j.ejca.2007
CGTG-102 (499 words) [view diff] exact match in snippet view article find links to article
Julien; Lichty, Brian D (2012). "Oncolytic viruses: a step into cancer immunotherapy". Virus Adaptation and Treatment. 4: 1–21. doi:10.2147/VAAT.S12980
Natural killer T cell (1,560 words) [view diff] exact match in snippet view article find links to article
Coch C, Schmidt-Wolf IG. Cytokine-induced killer cell (CIK) in cancer immunotherapy: report of the international registry on CIK cells (IRCC). J Cancer
TNFRSF18 (1,187 words) [view diff] exact match in snippet view article find links to article
of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy". Cancer Immunol. Immunother. 59 (9): 1367–77. doi:10.1007/s00262-010-0866-5
Cancer prevention (5,183 words) [view diff] exact match in snippet view article find links to article
in cancer immunotherapy research?". www.cancer.org. Retrieved 2018-03-09. Pardoll DM (March 2012). "The blockade of immune checkpoints in cancer immunotherapy"
Cancer in dogs (1,283 words) [view diff] exact match in snippet view article find links to article
12060. PMID 23981098. Regan, D; Guth, A; Coy, J; Dow, S (2016). "Cancer immunotherapy in veterinary medicine: Current options and new developments". The
Toll-like receptor (5,487 words) [view diff] exact match in snippet view article find links to article
agonist. Recently, resiquimod has been explored as an agent for cancer immunotherapy, acting through stimulation of tumor-associated macrophages. Several
Adoptive immunity (464 words) [view diff] exact match in snippet view article find links to article
ME (2008). "Adoptive cell transfer: a clinical path to effective cancer immunotherapy". Nature Reviews. Cancer. 8 (4): 299–308. doi:10.1038/nrc2355. PMC 2553205
Antigen (2,594 words) [view diff] exact match in snippet view article find links to article
Schumacher, Ton N.; Schreiber, Robert D. (April 3, 2015). "Neoantigens in cancer immunotherapy". Science. 348 (6230): 69–74. Bibcode:2015Sci...348...69S. doi:10
Antibody-dependent cellular cytotoxicity (1,643 words) [view diff] case mismatch in snippet view article find links to article
(2015). "NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy". Front Immunol. 6: 368. doi:10.3389/fimmu.2015.00368. PMC 4515552
Chemoimmunotherapy (988 words) [view diff] exact match in snippet view article find links to article
chemotherapy." Cancer research (2008).[1] Couzin-Frankel, Jennifer. "Cancer immunotherapy." (2013) Chen, Gang, and Leisha A. Emens. "Chemoimmunotherapy: reengineering
Medarex (522 words) [view diff] case mismatch in snippet view article find links to article
making the payment to Medarex $2.1B. Breakthrough of the Year: Cancer Immunotherapy, Science 20 December 2013, Vol. 342 no. 6165 pp. 1432-1433, DOI:
Rosenberg (surname) (787 words) [view diff] exact match in snippet view article
Rosenberg, American film director Steve Rosenberg, American surgeon and cancer immunotherapy pioneer Susanne Rosenberg (born 1957), Swedish folk music singer
Active immunotherapy (689 words) [view diff] exact match in snippet view article find links to article
PMC 3836274. PMID 19895242. Davis, Ian D (2000-06-01). "An overview of cancer immunotherapy". Immunology and Cell Biology. 78 (3): 179–195. doi:10.1046/j.1440-1711
TPBG (1,018 words) [view diff] exact match in snippet view article find links to article
appears to give 5T4 the potential to be a target for T cells in cancer immunotherapy. There has been extensive research into its role in antibody-directed
Regulatory T cell (5,611 words) [view diff] exact match in snippet view article find links to article
microenvironment has largely contributed to the unsuccessful outcomes of many cancer immunotherapy treatments. Depletion of Tregs in animal models has shown an increased
Signal-regulatory protein alpha (1,645 words) [view diff] exact match in snippet view article find links to article
Yanagita T (2017). "Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy". JCI Insight. 2 (1): e89140. doi:10.1172/jci.insight.89140. PMC 5214103
Immudex (1,413 words) [view diff] case mismatch in snippet view article find links to article
entered an agreement with the US cancer Immunotherapy consortium (CIC) and the European Association for Cancer Immunotherapy (CIMIT). The agreement dictates
Christopher E. Rudd (892 words) [view diff] exact match in snippet view article find links to article
down-regulate the inhibitory co-receptor programmed cell death-1 (PD-1) in cancer immunotherapy. Rudd's work has had important clinical outcomes as it laid the foundation
Amgen (2,558 words) [view diff] case mismatch in snippet view article find links to article
antibody technology". FierceBiotech. "Amgen, Xencor to Partner on Cancer Immunotherapy, Inflammation Drugs". GEN. "Amgen Buys Rights to Myeloma BiTE Immunotherapy
Exosome (vesicle) (6,267 words) [view diff] exact match in snippet view article
tolerance. Patient-derived exosomes have been employed as a novel cancer immunotherapy in several clinical trials. Exosomes offer distinct advantages that
American Association for Cancer Research (1,064 words) [view diff] case mismatch in snippet view article find links to article
Molecular Targets and Cancer Therapeutics Conference, the International Cancer Immunotherapy Conference, and the Biennial Meeting on Advances in Malignant Lymphoma;
Bradley Cooper (10,216 words) [view diff] case mismatch in snippet view article find links to article
2016, he participated in the launch of the Parker Institute for Cancer Immunotherapy that works for cancer patients. He served as an executive producer
B-cell receptor (2,061 words) [view diff] case mismatch in snippet view article find links to article
ISBN 978-3642038570. Merlo, Lauren M.F.; Mandik-Nayak, Laura (2013). Cancer Immunotherapy: Chapter 3-Adaptive Immunity: B Cells and Antibodies. London: Academic
MAGEA3 (1,165 words) [view diff] exact match in snippet view article find links to article
CCR-05-1203. PMID 16299236. Corporate Comms. "New data on MAGE-A3 cancer immunotherapy support potential novel options of treating non-small cell lung cancer
Tang Prize (1,074 words) [view diff] exact match in snippet view article find links to article
as immune inhibitory molecules that led to their applications in cancer immunotherapy." Two winners then won the Nobel Prize in Physiology or Medicine
Alice, Texas (2,245 words) [view diff] exact match in snippet view article find links to article
Lasker Prize, and the Breakthrough Prize for his development of cancer immunotherapy Chris Brazzell, Canadian Football League player and ex NFL player
Levamisole (2,554 words) [view diff] exact match in snippet view article find links to article
131.1. PMC 4781110. PMID 18050502. Dillman RO (February 2011). "Cancer immunotherapy". Cancer Biotherapy & Radiopharmaceuticals. 26 (1): 1–64. doi:10
Georges Mathé (1,063 words) [view diff] case mismatch in snippet view article find links to article
of hematopoietic and lymphoid tissues, Geneva, 1976, WHO; Mathé, Cancer Immunotherapy, New York, 1976, Springer: Mathé Cancer chemo-and immuno pharmacology
Brain metastasis (2,366 words) [view diff] exact match in snippet view article find links to article
Draghi A, Borch TH, Nuti M, Cortesi E, Svane IM, Donia M (May 2018). "Cancer immunotherapy in patients with brain metastases". Cancer Immunology, Immunotherapy
Neuvenge (1,055 words) [view diff] exact match in snippet view article find links to article
lead to cancer. "A successful (TCV) is considered a milestone for cancer immunotherapy." The only approved TCVs, as of 2010, are Provenge in the US and
Transplant rejection (3,094 words) [view diff] exact match in snippet view article find links to article
epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy". Immunology and Cell Biology. 83 (6): 674–86. doi:10.1111/j.1440-1711
Fas ligand (2,056 words) [view diff] exact match in snippet view article find links to article
Liljeström P, Uyttenhove C, Van den Eynde BJ (2017). "Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes". Nat Commun
Noxxon Pharma (500 words) [view diff] case mismatch in snippet view article find links to article
in October, 2018 during the 4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference in New York, NY, USA. A different Spiegelmer (NOX-E36
PD-L1 (2,362 words) [view diff] exact match in snippet view article find links to article
cells as checkpoint protein and was proposed as potential target in cancer immunotherapy in human clinic PD-L1 binds to its receptor, PD-1, found on activated
Roswell Park Comprehensive Cancer Center (1,923 words) [view diff] case mismatch in snippet view article find links to article
Complex and Rare Cancers Blue Distinction Center for Transplants Cancer Immunotherapy Trials Network Member (CITN) Commission on Cancer of the American
Robert Pittman (media executive) (2,343 words) [view diff] case mismatch in snippet view article
boards of the Rock and Roll Hall of Fame and the Parker Institute for Cancer Immunotherapy and is a former board member of the non-profit Lupus Research Alliance
Asunercept (752 words) [view diff] exact match in snippet view article find links to article
Liljeström P, Uyttenhove C, Van den Eynde BJ (2017). "Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes". Nat Commun
Buchanan Medal (971 words) [view diff] exact match in snippet view article find links to article
fundamental cell biological mechanisms that drive cytotoxic T-cell killing, laying the foundations for informed application of cancer immunotherapy." -
Boehringer Ingelheim (2,529 words) [view diff] exact match in snippet view article find links to article
acquired Amal Therapeutics SA, boostings the business' focus on cancer immunotherapy and vaccine treatments. Boehringer Ingelheim works in human pharmaceuticals
Jane Grogan (460 words) [view diff] exact match in snippet view article find links to article
including anti-lymphotoxin in rheumatoid arthritis and anti-TIGIT for cancer immunotherapy Immunotherapies that harness the activity of the immune system against
Interleukin 11 (2,285 words) [view diff] no match in snippet view article find links to article
TL, Ernst M (2015). "IL-11 signaling as a therapeutic target for cancer". Immunotherapy. 7 (4): 441–53. doi:10.2217/imt.15.17. PMID 25917632. Tao L, Huang
CTLA-4 (3,286 words) [view diff] exact match in snippet view article find links to article
Pardoll DM (March 2012). "The blockade of immune checkpoints in cancer immunotherapy". Nature Reviews. Cancer. 12 (4): 252–64. doi:10.1038/nrc3239. PMC 4856023
Cryoablation (2,408 words) [view diff] exact match in snippet view article find links to article
doi:10.5152/dir.2019.18278 – via ProQuest. Sidana Abhinav (2014). "Cancer immunotherapy using tumor cryoablation". Immunotherapy. 6 (1): 85–93. doi:10.2217/imt
Cryoimmunotherapy (1,713 words) [view diff] exact match in snippet view article find links to article
ablation and immunotherapy Photoimmunotherapy Sidana Abhinav (2014). "Cancer immunotherapy using tumor cryoablation". Immunotherapy. 6 (1): 85–93. doi:10.2217/imt
Bempegaldesleukin (545 words) [view diff] exact match in snippet view article find links to article
kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy". PLOS ONE. 12 (7): e0179431. doi:10.1371/journal.pone.0179431. "Bristol-Myers
Ariel Hollinshead (943 words) [view diff] exact match in snippet view article find links to article
Concannon, J (15 September 1987). "Adjuvant specific active lung cancer immunotherapy trials. Tumor-associated antigens" (PDF). Cancer. 60 (6): 1249–62
V-set and immunoglobulin domain containing 1 (283 words) [view diff] exact match in snippet view article find links to article
(January 2006). "Glycoprotein A34, a novel target for antibody-based cancer immunotherapy". Cancer Immun. 6: 2. PMID 16405301. Chen Y, Pan K, Li S, Xia J,
List of philanthropists (3,532 words) [view diff] case mismatch in snippet view article find links to article
Engagement ; and donated $250 million to create the Parker Institute for Cancer Immunotherapy Shahrukh Khan - the only Indian to receive UNESCO Pyramide con Marni
Yvonne Mburu (841 words) [view diff] exact match in snippet view article find links to article
Cancer Research Institute, New York, to continue her research in cancer immunotherapy at the Curie Institute. She worked on immunotherapy for the treatment
H. Lee Moffitt Cancer Center & Research Institute (2,356 words) [view diff] exact match in snippet view article find links to article
for male HPV vaccination internationally. In September 2014, a new cancer immunotherapy for melanoma patients called Keytruda became the first anti-PD-1
Dendritic cell (3,824 words) [view diff] case mismatch in snippet view article find links to article
Weissleder R, Pittet MJ (December 2018). "Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines
Memorial Sloan Kettering Cancer Center (2,790 words) [view diff] exact match in snippet view article find links to article
Southam conducted pioneering clinical research on virotherapy and cancer immunotherapy at MSK; however he conducted his research on people without their
Heparan sulfate (3,358 words) [view diff] exact match in snippet view article find links to article
Mitchell; Kim, Heungnam (February 2011). "Glypican-3: a new target for cancer immunotherapy". European Journal of Cancer (Oxford, England: 1990). 47 (3): 333–338
Akseli Hemminki (799 words) [view diff] exact match in snippet view article find links to article
and Docrates Cancer Center. Akseli Hemminki’s research focuses on cancer immunotherapy and especially on oncolytic adenoviruses. The goal of his research
Angiogenesis inhibitor (2,855 words) [view diff] exact match in snippet view article find links to article
effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy". Anticancer Research. 22 (3): 1737–54. PMID 12168863. Oba K, Teramukai
André Choulika (1,104 words) [view diff] exact match in snippet view article find links to article
partnerships with Pfizer and Servier for collaboration on their cancer immunotherapy products. In 2018, Allogene assumed the global strategic partnership
Margaret Hamburg (1,757 words) [view diff] case mismatch in snippet view article find links to article
Commonwealth Fund, the Simons Foundation, the Parker Institute for Cancer Immunotherapy, the Urban Institute, and the American Museum of Natural History
Wistar Institute (2,153 words) [view diff] exact match in snippet view article find links to article
DNA-based technologies for prevention of infectious diseases and for cancer immunotherapy. The HIV-1 research program at Wistar is co-leading a consortium
TAF6 (1,387 words) [view diff] exact match in snippet view article find links to article
experimental and clinical immunopharmacology data applicable to cancer immunotherapy". Ann N Y Acad Sci. 277 (00): 467–84. doi:10.1111/j.1749-6632.1976
Signaling lymphocytic activation molecule (1,112 words) [view diff] exact match in snippet view article find links to article
1111/cts.12532. PMC 5944582. PMID 29272564. Sell, Stewart (June 2017). "Cancer immunotherapy: Breakthrough or "deja vu, all over again"?". Tumor Biology. 39 (6):
Association of Cancer Physicians (661 words) [view diff] case mismatch in snippet view article find links to article
Oncology, Clinical Publishing, 2014 Cancer in the United Kingdom Cancer Immunotherapy Precision Medicine Chemotherapy Experimental cancer treatments Clinical
The Getaway World Tour (5,106 words) [view diff] case mismatch in snippet view article find links to article
Parker and The Parker Foundation Launch for The Parker Institute for Cancer Immunotherapy The band performed a sixteen-song set at the Jazz & Heritage Festival
Cancer Breakthroughs 2020 (1,351 words) [view diff] no match in snippet view article find links to article
1-leading-biopharmaceutical-companies-accelerate-development-new-cancer-immunotherapy-strategies-more-patients https://www.reuters
Retrogenix (797 words) [view diff] exact match in snippet view article find links to article
including the identification of TNFR2 as a potential target for cancer immunotherapy.[citation needed] Cell microarray off-target profiling assesses the
Lymphatic system (5,398 words) [view diff] exact match in snippet view article find links to article
Herman (June 2019). "Tertiary lymphoid structures in the era of cancer immunotherapy" (PDF). Nature Reviews. Cancer. 19 (6): 307–325. doi:10.1038/s41568-019-0144-6
Hoffmann-La Roche (3,959 words) [view diff] case mismatch in snippet view article find links to article
Medicine". Reuters. 19 June 2018 – via uk.reuters.com. "Roche Acquires Cancer Immunotherapy Developer Tusk Therapeutics". 28 September 2018. "Roche buys U.S
Yu Dechao (738 words) [view diff] case mismatch in snippet view article find links to article
Retrieved Oct 10, 2016. Shuren Zhang (30 May 2016). Progress in Cancer Immunotherapy. Springer. pp. 244–. ISBN 978-94-017-7555-7. Liang, M. (2018). "Oncorine
Ira Pastan (1,794 words) [view diff] exact match in snippet view article find links to article
and his colleague Mark Willingham and is a promising target for cancer immunotherapy, because it is expressed on many cancers: mesothelioma, ovarian,
KLRG1 (1,571 words) [view diff] exact match in snippet view article find links to article
Mahoney KM, Rennert PD, Freeman GJ (August 2015). "Combination cancer immunotherapy and new immunomodulatory targets". Nature Reviews. Drug Discovery
MAGEA11 (1,760 words) [view diff] exact match in snippet view article find links to article
Y, Zhou X, Shan B (2011). "MAGE-A family: Attractive targets for cancer immunotherapy". Vaccine. 29 (47): 8496–8500. doi:10.1016/j.vaccine.2011.09.014
AstraZeneca (4,836 words) [view diff] case mismatch in snippet view article find links to article
Dips". GEN. "GEN - News Highlights:MedImmune, Juno Team Up to Study Cancer Immunotherapy Combo". GEN. "Eolas and AstraZeneca Agree to Develop Orexin-1 Receptor
Liver cancer (4,572 words) [view diff] case mismatch in snippet view article find links to article
September 2018. Immunitor Phase 3 trial of hepcortespenlisimut-L, Liver Cancer Immunotherapy "Archived copy". Archived from the original on 2015-05-30. Retrieved
Interleukin 6 (5,530 words) [view diff] exact match in snippet view article find links to article
(January 2015). "Mechanisms and applications of interleukins in cancer immunotherapy". International Journal of Molecular Sciences. 16 (1): 1691–710.
Carolyn R. Bertozzi (2,409 words) [view diff] exact match in snippet view article find links to article
R. (2016-08-22). "Precision glycocalyx editing as a strategy for cancer immunotherapy". Proceedings of the National Academy of Sciences. 113 (37): 10304–10309
BK channel (3,663 words) [view diff] exact match in snippet view article find links to article
Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy". International Immunopharmacology. 22 (2): 427–43. doi:10.1016/j
Merck Group (3,533 words) [view diff] exact match in snippet view article find links to article
of success in patient recruitment, with its MUC1 antigen-specific cancer immunotherapy drug, tecemotide (L-BLP25), missing its Phase I/II endpoint of increasing
Interleukin 15 (3,637 words) [view diff] exact match in snippet view article find links to article
"Rescue of nonlytic Newcastle Disease Virus (NDV) expressing IL-15 for cancer immunotherapy". Virus Research. 233: 35–41. doi:10.1016/j.virusres.2017.03.003
Bristol-Myers Squibb (4,391 words) [view diff] exact match in snippet view article find links to article
Bavarian Nordic's phase III prostate specific antigen targeting cancer immunotherapy. Bavarian Nordic would receive an upfront payment of $60 million
Immunodominance (1,082 words) [view diff] exact match in snippet view article find links to article
expressed by the virus. Immunodominance can also have implications in cancer immunotherapy. Similar to HIV-escape, cancer can escape the immune system’s detection
Programmed cell death protein 1 (4,805 words) [view diff] exact match in snippet view article find links to article
therapy by inhibition of negative immune regulation". A number of cancer immunotherapy agents that target the PD-1 receptor have been developed. One such
Mir-17 microRNA precursor family (3,992 words) [view diff] exact match in snippet view article find links to article
"miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy". J Transl Med. 8 (1): 17. doi:10.1186/1479-5876-8-17. PMC 2836279
HAVCR2 (1,845 words) [view diff] exact match in snippet view article find links to article
PMID 22426209. Anderson AC (May 2014). "Tim-3: an emerging target in the cancer immunotherapy landscape". Cancer Immunology Research. 2 (5): 393–8. doi:10.1158/2326-6066
Elaine Mardis (1,978 words) [view diff] exact match in snippet view article find links to article
therapeutic decision-making, and into the design of new approaches to cancer immunotherapy. In 2015, Mardis helped launch an open access, precision medicine
Immunologic checkpoint (386 words) [view diff] exact match in snippet view article find links to article
regulation and disease Sabrina Ceeraz , Elizabeth C. Nowak , and Randolph J. Noelle The blockade of immune checkpoints in cancer immunotherapy, Drew M. Pardoll
Macrophage (7,837 words) [view diff] exact match in snippet view article find links to article
(ADCC)and this mechanism has been proposed to be important for certain cancer immunotherapy antibodies. It has been observed that increased number of pro-inflammatory
Symphogen (1,538 words) [view diff] exact match in snippet view article find links to article
receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy" PNAS (102) 1915–20 Retrieved 17 November 2011. Pedersen MW, Jacobsen
Seung-Yong Seong (1,230 words) [view diff] exact match in snippet view article find links to article
immune response initiation. His lab also studies dendritic cells, cancer immunotherapy and single domain antibody therapies. His current research is centered
Fibroblast activation protein, alpha (2,017 words) [view diff] exact match in snippet view article find links to article
stromal antigen, fibroblast activation protein: implication for cancer immunotherapy". Clinical Cancer Research. 11 (15): 5566–71. doi:10.1158/1078-0432
Red Hot Chili Peppers (12,809 words) [view diff] case mismatch in snippet view article find links to article
Napster founder Sean Parker for his launch of The Parker Institute for Cancer Immunotherapy. Chad Smith and Will Ferrell hosted the Red Hot Benefit Comedy +
Arie Belldegrun (2,002 words) [view diff] exact match in snippet view article find links to article
commercial-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy
Carter F. Bales (1,445 words) [view diff] case mismatch in snippet view article find links to article
Retrieved 2017-01-11. "Cancer Research Institute - The Leader in Cancer Immunotherapy - CRI". cancerresearch.org. Retrieved 2017-01-11. "Carter F. Bales
Wnt signaling pathway (6,934 words) [view diff] exact match in snippet view article find links to article
PMID 30963603. Ho M, Kim H (February 2011). "Glypican-3: a new target for cancer immunotherapy". European Journal of Cancer. 47 (3): 333–8. doi:10.1016/j.ejca.2010
Autologous immune enhancement therapy (2,022 words) [view diff] exact match in snippet view article find links to article
AIET with specific chemotherapy or radiotherapy as the future of cancer immunotherapy. In the beginning Immunotherapy treatments involved administration
Glypican (2,309 words) [view diff] exact match in snippet view article find links to article
PMID 10656689. Ho M, Kim H (February 2011). "Glypican-3: a new target for cancer immunotherapy". European Journal of Cancer. 47 (3): 333–8. doi:10.1016/j.ejca.2010
Seattle Cancer Care Alliance (2,441 words) [view diff] exact match in snippet view article find links to article
(2005-04-28). "Adoptive T cell therapy: Addressing challenges in cancer immunotherapy". Journal of Translational Medicine. 3 (1): 17. doi:10.1186/1479-5876-3-17
Photoimmunotherapy (987 words) [view diff] exact match in snippet view article find links to article
immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy". Nat Commun. 7: 13193. Bibcode:2016NatCo...713193C. doi:10.1038/ncomms13193
Michael Bloomberg (13,421 words) [view diff] case mismatch in snippet view article find links to article
Bloomberg also funded the launch of the Bloomberg–Kimmel Institute for Cancer Immunotherapy within the Johns Hopkins School of Medicine in East Baltimore, with
MHC multimer (2,322 words) [view diff] exact match in snippet view article find links to article
as those that target self cells and lead to autoimmune disease. Cancer immunotherapy and vaccine development can also be largely influenced by this technology
Chinese herbology (6,889 words) [view diff] exact match in snippet view article find links to article
popular belief, Ganoderma lucidum mushroom extract, as an adjuvant for cancer immunotherapy, appears to have the potential for toxicity. Also, adulteration of
Aphanizomenon flos-aquae (dietary supplement) (2,807 words) [view diff] exact match in snippet view article
polysaccharide preparations that are currently used clinically for cancer immunotherapy. Research also characterizes the effect of a water-soluble preparation
Fungus (17,493 words) [view diff] exact match in snippet view article find links to article
effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy". Anticancer Research. 22 (3): 1737–54. PMID 12168863. Firenzuoli
OSMECON (1,312 words) [view diff] case mismatch in snippet view article find links to article
Neuroscience of Adolescence and Meditation. Theme of Poster Presentation: Cancer Immunotherapy, Personalised Medicine There were about 1,100 delegates attending
Raccoonpox virus (1,923 words) [view diff] exact match in snippet view article find links to article
treatment technique in infectious disease, ex vivo therapies, and cancer immunotherapy. *Under clinical trials as well as some licensed commercialization
Alberto Mantovani (1,790 words) [view diff] case mismatch in snippet view article find links to article
cancer: myth or reality?. Springer. 2008. Academic press, ed. (2013). Cancer Immunotherapy. Macrophages: biology and role in the pathology of diseases. Springer
Gamma delta T cell (4,344 words) [view diff] exact match in snippet view article find links to article
secretion of γδ T cells suggest that these cells would be effective in cancer immunotherapy. Trials in numerous cancers (renal carcinoma, leukemia, lung cancer)
Telomerase reverse transcriptase (5,263 words) [view diff] exact match in snippet view article find links to article
PMID 10403642. Rosenberg SA (March 1999). "A new era for cancer immunotherapy based on the genes that encode cancer antigens". Immunity. 10 (3):
Glypican 3 (2,509 words) [view diff] exact match in snippet view article find links to article
PMID 17258707. Ho M, Kim H (February 2011). "Glypican-3: a new target for cancer immunotherapy". European Journal of Cancer. 47 (3): 333–8. doi:10.1016/j.ejca.2010
Daniel A. Portnoy (1,282 words) [view diff] exact match in snippet view article find links to article
now being evaluated for clinical application as adjuvants and for cancer immunotherapy. Dr. Portnoy has been awarded a number of honors over the course
Arnold Orville Beckman (6,808 words) [view diff] case mismatch in snippet view article find links to article
from Arnold and Mabel Beckman Foundation Establishes New Model for Cancer Immunotherapy". Business Wire. Retrieved 7 March 2014. Saliba, Jaimee (Oct 29,
Photodynamic therapy (8,681 words) [view diff] exact match in snippet view article find links to article
immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy". Nat Commun. 7: 13193. Bibcode:2016NatCo...713193C. doi:10.1038/ncomms13193
Killer activation receptor (2,197 words) [view diff] case mismatch in snippet view article find links to article
Barber, Amorette; Zhang, Tong (2006). "NK Cell Receptors as Tools in Cancer Immunotherapy". Advances in Cancer Research. 95. pp. 249–292. doi:10.1016/S0065-230X(06)95007-6
Traditional Chinese medicine (19,751 words) [view diff] exact match in snippet view article find links to article
popular belief, Ganoderma lucidum mushroom extract, as an adjuvant for cancer immunotherapy, appears to have the potential for toxicity. A 2013 review suggested
Lymphopoiesis (5,997 words) [view diff] case mismatch in snippet view article find links to article
Immunology". www.immunology.org. Retrieved 2019-06-14. Tumor Immunity and Cancer Immunotherapy Medical Immunology, page 22 Medical Immunology, p. 123 Fundamental
Prostate cancer (17,541 words) [view diff] exact match in snippet view article find links to article
Hammerstrom AE, Cauley DH, Atkinson BJ, Sharma P (August 2011). "Cancer immunotherapy: sipuleucel-T and beyond". Pharmacotherapy. 31 (8): 813–28. doi:10
T-cell depletion (2,610 words) [view diff] exact match in snippet view article find links to article
"Self-tolerance eliminates CD4+ T, but not CD8+ T or B, cells corrupting cancer immunotherapy". European Journal of Immunology. 44 (7): 1956–1966. doi:10.1002/eji
Macrophage polarization (2,507 words) [view diff] exact match in snippet view article find links to article
promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy". Nature Biomedical Engineering. 2 (8): 578–588. doi:10.1038/s41551-018-0236-8
Induced stem cells (25,179 words) [view diff] exact match in snippet view article find links to article
for cancer immunotherapy and other medical applications. Invariant natural killer T (iNKT) cells have great clinical potential as adjuvants for cancer immunotherapy
CD4+ T cells and antitumor immunity (3,980 words) [view diff] exact match in snippet view article find links to article
Qiu et al., 1999 G. Qiu, J. Goodchild, R.E. Humphreys and M. Xu, Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor
MiR-155 (10,181 words) [view diff] case mismatch in snippet view article find links to article
progression". The 14th CIMT Annual Meeting Mechanisms of Efficacy in Cancer Immunotherapy, Mainz, Germany, 2016. Sonkoly E, Janson P, Majuri ML, Savinko T
Canadian university scientific research organizations (6,995 words) [view diff] case mismatch in snippet view article find links to article
Maisonneuve-Rosemont, Montréal, Quebec, Centre for Commercialization of Cancer Immunotherapy – C3i (2016–2021) – Montréal, Quebec, Centre for Commercialization
Epithelioid sarcoma (6,677 words) [view diff] exact match in snippet view article find links to article
Julien; Lichty, Brian D (2012). "Oncolytic viruses: a step into cancer immunotherapy". Virus Adaptation and Treatment. 4: 1–21. doi:10.2147/VAAT.S12980
Peter Fecci (2,102 words) [view diff] case mismatch in snippet view article find links to article
Publishers. Fecci PE, Chen C, Baumeister S, Dranoff G. "Chapter 16: Cancer Immunotherapy." In Vaccine Design: Innovative Approaches and Novel Strategies 2nd
2006 Queen's Birthday Honours (Australia) (92 words) [view diff] exact match in snippet view article
medical research through significant contributions in the field of cancer immunotherapy. Rosemary Follett For service to the Australian Capital Territory
Secreted frizzled-related protein 1 (6,260 words) [view diff] no match in snippet view article find links to article
isolated from stool samples has been used to screen for colorectal cancer. Immunotherapy is a treatment used to produce immunity to a disease or enhance
Murine respirovirus (26,316 words) [view diff] exact match in snippet view article find links to article
with oncolytic Sendai virus, retrieved 2019-08-21 [1], "Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic
Timeline of the San Francisco Bay Area (26,120 words) [view diff] case mismatch in snippet view article find links to article
Sean Parker donates $250 million to create the Parker Institute for Cancer Immunotherapy, with funds going to over 300 scientists at 40 laboratories, in 6